Mallinckrodt and Endo to combine to create a global pharmaceuticals leader
MLex Summary: Mallinckrodt Pharmaceuticals and Endo, Inc have agreed to merge in a $6.7 billion deal. The transaction, which has been approved by the boards of directors of both companies, is...To view the full article, register now.
Already a subscriber? Click here to view full article